Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Incyte Corporation
Incyte Corporation
Pfizer
Children's Oncology Group
EMD Serono
University of Virginia
Bayer
National Cancer Institute (NCI)
OHSU Knight Cancer Institute
Bristol-Myers Squibb
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Columbia University
Radiation Therapy Oncology Group
Masonic Cancer Center, University of Minnesota
Barbara Ann Karmanos Cancer Institute
Dana-Farber Cancer Institute
Duke University
Vanderbilt-Ingram Cancer Center